Policy Working Group for Switch Biomanufacturing

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on October 21, 2025.

Award Information

This solicitation resulted in an award to for approximately $692,875 on October 21, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: HR001126CE009
Award Amount: $692,875
Award Date: October 21, 2025

View full award details on USASpending.gov

Key Takeaways

Set-aside for No Set Aside businesses
Work to be performed in ARLINGTON, VA
Industry: Research and Development in Biotechnology (except Nanobiotechnology)

Contract Details

Notice ID: HR001124S0034
Opportunity Type: Award Notice
Agency: DEPT OF DEFENSE
Sub-Agency: DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office: DEF ADVANCED RESEARCH PROJECTS AGCY
Posted Date: Tuesday, October 21, 2025
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: AC12
Set-Aside: No Set Aside
Place of Performance: ARLINGTON, VA, 222032114
Status: Active

View on SAM.gov

Description

This contract is fixed price and awarded competitively.

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in ARLINGTON, VA. This set-aside designation means eligible businesses face reduced competition from larger firms.

Similar Opportunities

AJ11-VA Depleted Uranium Program PO 512C50314

VETERANS AFFAIRS, DEPARTMENT OF•MD

Q-RNAscope In-House Assay

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•MD

Low-cost, Connected, Digital Lateral Flow Platform to Detect Influenza A, Influenza B, and SARS-Cov -2 for use in Over-the-Counter (OTC) Settings

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•DC

A-High Throughput Transcriptomics (HTTr)

ENVIRONMENTAL PROTECTION AGENCY•OH

human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)

DEPT OF DEFENSE•MD